Key Market Indicators
Germany's insulin export market is projected to see modest growth, reaching an estimated $3.7 billion by 2028, up from $3.6 billion in 2023. This marks an average annual growth rate of 0.3%. The country's insulin supply has been on an upward trajectory, increasing by 2.2% annually since 1996. In the global ranking, Germany's insulin export market is closely followed by France, Italy, and China, occupying the second, third, and fourth spots, respectively. On the import front, Germany's insulin market is anticipated to hit approximately $692 million by 2028, rising from $674 million in 2023. This also represents a 0.3% annual growth rate. German demand for insulin has experienced a slower but steady increase, growing at an average rate of 0.6% per year since 1996.
